UCF researcher receives $3.4 million to develop new antibiotic to treat tuberculosis

A College of Medicine researcher is developing a new antibiotic related to penicillin to treat tuberculosis (TB) and related lung infections.

Suprachoroidal Axitinib Shows Early Durability, Excellent Safety in Wet AMD

Suprachoroidal axitinib (Inlyta) for the treatment of wet age-related macular degeneration (AMD) showed no safety signals at all doses tested in an early-stage trial, with

August 30, 2023

Surgical LAA Closure Rises to the Top in STS Guideline for Afib

SAN ANTONIO — The Society of Thoracic Surgeons (STS) made a big push for left atrial appendage (LAA) occlusion in updated guidelines for the surgical

January 29, 2024

Zebrafish model reveals how BCG vaccine triggers immune response in bladder cancer

Using zebrafish “Avatars”, an animal model developed by the Cancer Development and Innate Immune Evasion lab at the Champalimaud Foundation (CF), led by Rita Fior,

August 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.